TIPS FOR
SPOTTING BAD neurotransmitter testing
LABORATORY QUALITY ASSURANCE
The quality assurance
process in a medical laboratory,
not directed by a hospital based
board pathologist board
certified in laboratory medicine,
can be sloppy or easily mis-represented. So how can a doctor in a
clinic know if the quality
assurance in the laboratory
reporting out medical results
meets expected guidelines? One
answer is to examine represents
of the peer reviewed scientific
medical literature as made by the
lab that the testing is
based on in comparison to what
the peer reviewed scientific
medical literature actually
says.
HINTS YOU
HAVE neurotransmitter testing FROM A LAB
WHOSE QUALITY ASSURANCE PROCESS NEEDS TO
BE SCRUTINIZED
You may have laboratory
quality assurance issues when:
1.
When
the lab consistently demonstrates that 5-HTP
increases urinary serotonin levels there is
a mis-representation of medical scientific
literature by the lab and laboratory quality
assurance needs to be scrutinized.
THE SCIENCE:
There is no direct correlation between
administration of 5-HTP and urinary
serotonin levels the only correlation that
exists is when the urinary serotonin phase
of response is determined with varied 5-HTP
dosing. If a lab tries to tell you that
it can demonstrate a consistent
elevation of serotonin with
urinary neurotransmitter testing
in the administration of 5-HTP, inaccurate
results are being reported, the lab has miscalibrated lab
reports, or equipment.
2.
If the lab claims that serotonin, dopamine,
norepinephrine, or epinephrine found in the
urine are neurotransmitters that were
filtered at the glomerulous of the kidney
and excreted into the urine there is a
mis-representation of medical scientific
literature by the lab and laboratory quality
assurance needs to be scrutinized.
THE SCIENCE:
Peer reviewed medical literature is clear,
urinary serotonin, dopamine, norepinephrine,
and epinephrine are not neurotransmitters
that were filtered by the kidney and
excreted into the urine they are
neurotransmitters that were synthesized by
the kidneys. There is no correlation between
urinary neurotransmitter levels and
neurotransmitter levels of the brain or
peripheral circulation.
3.
The lab recommends
obtaining serotonin and
dopamine baseline
urinary neurotransmitter testing prior to
treatment with 5-HTP,
tyrosine, and/or dopa
there is a
mis-representation of
medical scientific
literature by the lab
and laboratory quality
assurance needs to be
scrutinized.
THE SCIENCE:
Urinary serotonin and
dopamine prior
to treatment
with 5-HTP, tyrosine, levodopa, and cysteine is in the
"endogenous
state". Once
significant
levels of 5-HTP, tyrosine, levodopa, and cysteine are given
the urinary
serotonin and
dopamine are in
the "competitive
inhibition"
state. Baseline urinary
neurotransmitter testing in the
endogenous state prior to
administration
of 5-HTP, tyrosine, levodopa, and cysteine has no
correlation with
testing
performed once
in the "competitive
inhibition state"
seen when taking
5-HTP, tyrosine, levodopa, and cysteine.
4.
If the lab suggests that
serotonin and dopamine
urinary neurotransmitter testing correlates with
peripheral and/or
central nervous system
serotonin and dopamine
levels there is a
mis-representation of
medical scientific
literature by the lab
and laboratory quality
assurance needs to be
scrutinized.
THE SCIENCE:
Urinary
serotonin,
dopamine,
norepinephrine,
and epinephrine
are
neurotransmitter
molecules that
are synthesized
by the kidneys
and have no
correlation with
central or
peripheral
serotonin and
dopamine neurotransmitter
levels.
5.
The lab doesn't
understand or determine
"the three phases of
serotonin and dopamine"
in urinary
neurotransmitter
response to amino acid
administration or claims
there is a
mis-representation of
medical scientific
literature by the lab
and laboratory quality
assurance needs to be
scrutinized.
THE SCIENCE:
As noted in the
University of
Minnesota
Medical School
paper the only
correlation that
exists between
administration
of 5-HTP, tyrosine, levodopa, and cysteine and
serotonin and
dopamine urinary
neurotransmitter testing is the
three phases of
response when
the 5-HTP, tyrosine, levodopa, and cysteine dosing is
changed when two
separate testing
are obtained.
6.
If the lab asserts that
serotonin, dopamine,
norepinephrine, or
epinephrine cross the
blood brain barrier
there is a
mis-representation of
medical scientific
literature by the lab
and laboratory quality
assurance needs to be
scrutinized.
THE SCIENCE:
Serotonin,
dopamine,
norepinephrine,
and epinephrine
neurotransmitter
molecules do not
cross the blood
brain barrier.
Despite the fact
that this has
been established
for years, we
continue to hear
from doctors
that there are labs
recommending
baseline urinary
neurotransmitter testing who assert
that the
serotonin, dopamine,
norepinephrine,
and epinephrine
neurotransmitter
molecules cross the blood
brain barrier,
which they do
not. |
